Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Estradiol valerate

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Estradiol valerate used for?
The FDA-approved label (Delestrogen, Par Health USA, LLC, May 13, 2026) says: “DELESTROGEN (estradiol valerate injection, USP) is indicated in the: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Estradiol valerate have a boxed warning?
Yes. The FDA label for Delestrogen has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
Is there a shortage of Estradiol valerate?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Estradiol valerate been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Estradiol valerate?
4 companies list prescription products of Estradiol valerate in the FDA NDC Directory, including Xiromed, LLC, Hikma Pharmaceuticals USA Inc. and American Regent, Inc..

What Estradiol valerate is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

DELESTROGEN (estradiol valerate injection, USP) is indicated in the: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. …

— FDA label: Delestrogen, Par Health USA, LLC, effective May 13, 2026. Read the full label on DailyMed →

The FDA has 4 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

This label has a boxed warning. Read it on the full label →

4 of 4 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsInjection · Injection, solution
RouteIntramuscular
Prescription products10 in the FDA NDC Directory
Brand namesDelestrogen

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Estradiol valerate, by strength and form
Strength and formGeneric or brandPharmacies pay
estradiol valerate 10 mg/mL
injection
Generic $18.37 per mL
estradiol valerate 10 mg/mL
injection
Brand: Delestrogen $25.50 per mL
estradiol valerate 20 mg/mL
injection
Generic $22.96 per mL
estradiol valerate 20 mg/mL
injection
Brand: Delestrogen $35.78 per mL
estradiol valerate 20 mg/mL
injection, solution
Generic $22.96 per mL
estradiol valerate 40 mg/mL
injection
Generic $37.82 per mL
estradiol valerate 40 mg/mL
injection, solution
Generic $37.82 per mL

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA009402
DELESTROGEN
Ph HealthJuly 15, 1954 27, latest February 15, 2024
2024: Labeling · 2022: Labeling · 2017: Labeling

Generic approvals (3)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)206620, 206715, 310189, 310190, 310191
SPL set ID of the quoted labele8f94df9-0692-4462-a7f0-fe019a0a3f07
FDA labels (SPL)4
FDA applicationsNDA009402, 3 ANDA
Active ingredients (FDA)ESTRADIOL VALERATE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Delestrogen, Par Health USA, LLC, effective May 13, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers